AG
DERM

Aperio Group’s Dermira, Inc. DERM Stock Holding History

Aperio Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,463
Closed -$235K – 2440
2019
Q4 		$235K Sell
15,463
-704
-4% -$6.08K ﹤0.01% 2148
2019
Q3 		$104K Buy
16,167
+1,477
+10% +$12.3K ﹤0.01% 2238
2019
Q2 		$140K Buy
14,690
+2,878
+24% +$31K ﹤0.01% 2297
2019
Q1 		$160K Sell
11,812
-10,621
-47% -$88.6K ﹤0.01% 2195
2018
Q4 		$161K Sell
22,433
-3,011
-12% -$32.9K ﹤0.01% 2176
2018
Q3 		$278K Buy
25,444
+616
+2% +$6.21K ﹤0.01% 2050
2018
Q2 		$228K Buy
24,828
+13,867
+127% +$129K ﹤0.01% 2123
2018
Q1 		$88K Buy
10,961
+3,310
+43% +$72.1K ﹤0.01% 2222
2017
Q4 		$213K Buy
+7,651
New +$203K ﹤0.01% 2125

Aperio Group's DERM Position: Q1 2020 in Review

Aperio Group sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 15,463 shares — an estimated $235K sold.

Aperio Group first reported a position in DERM in Q4 2017 and held it in 9 quarters. The position peaked at $278K in Q3 2018. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Aperio Group reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Aperio Group sold 15,463 Dermira, Inc. shares in Q1 2020, an estimated $235K.
  • Aperio Group first reported a position in Dermira, Inc. in Q4 2017 and held it in 9 quarters.
  • Aperio Group's Dermira, Inc. position peaked at $278K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.